Position in VRTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$15,398
+$1,556 QoQ
Shares Held
31
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,615
of 1,745 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caitlin John, LLC holds $1,210,316 across 23 Biotechnology names. VRTX ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
12,270 | $667,609 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,018 | $401,164 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
560 | $43,830 | |
| 4 | HELP |
Cybin Inc.
|
5,000 | $33,050 | |
| 5 | DRTS |
Alpha Tau Medical Ltd.
|
2,101 | $26,430 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
31 | $15,398 | |
| 7 | GTBP |
GT Biopharma, Inc.
|
16,500 | $8,085 | |
| 8 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,000 | $4,810 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,398 | 31 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $13,842 | 31 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,054 | 31 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $12,140 | 31 | Shares | Defined | 2025-11-12 | |
| 2024-12-31 | $12,483 | 31 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $14,417 | 31 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,530 | 31 | Shares | Sole | 2025-01-27 | |
| 2024-03-31 | $12,958 | 31 | Shares | Sole | 2025-01-27 | |
| 2023-12-31 | $12,613 | 31 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||